Ping Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ping Wang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Yanhui Xu
Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai, China
18 shared publications Huirong Yang
Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, 131 Dong An Road, Mingdao Building, Room 715, Shanghai 200032, China
9 shared publicationsZe Li
Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, 131 Dong An Road, Mingdao Building, Room 715, Shanghai 200032, China
9 shared publicationsYan Lin
The ‡‡Department of Chemistry, University of Nebraska, Lincoln, Nebraska 68588-0304
6 shared publicationsJian Fang
Key Laboratory of Molecular Medicine, Ministry of Education, Department of Systems Biology for Medicine, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
5 shared publicationsJingdong Cheng
Key Laboratory of Molecular Medicine, Ministry of Education, Department of Systems Biology for Medicine, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
5 shared publications
Latest Publications
- 24 February 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain
Significance: Chronic pain is one of the most pressing national healthcare problems, and as a result, chronic pain was named by the NIH as the “silent epidemic.” Consequentially, chronic pain has directly contributed to the disproportionate increase in opioid use in America. However, thus far, there has been little progress in discovery of alternative noninvasive therapeutics for chronic pain. The current report outlines the repurposing of three tetracyclines for treatment of neuropathic pain by targeting the catalytic domain of EphB1 kinase. These results can be readily applicable clinically for treatment of neuropathic pain and provide proof of concept for the development of molecules for targeting Eph/ephrin-mediated pathologies.
- 24 February 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain
Significance: Chronic pain is one of the most pressing national healthcare problems, and as a result, chronic pain was named by the NIH as the “silent epidemic.” Consequentially, chronic pain has directly contributed to the disproportionate increase in opioid use in America. However, thus far, there has been little progress in discovery of alternative noninvasive therapeutics for chronic pain. The current report outlines the repurposing of three tetracyclines for treatment of neuropathic pain by targeting the catalytic domain of EphB1 kinase. These results can be readily applicable clinically for treatment of neuropathic pain and provide proof of concept for the development of molecules for targeting Eph/ephrin-mediated pathologies.
- Open Access
- 5 April 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11197
Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its histone recognition
UHRF1 is an important epigenetic regulator for maintenance DNA methylation. UHRF1 recognizes hemi-methylated DNA (hm-DNA) and trimethylation of histone H3K9 (H3K9me3), but the regulatory mechanism remains unknown. Here we show that UHRF1 adopts a closed conformation, in which a C-terminal region (Spacer) binds to the tandem Tudor domain (TTD) and inhibits H3K9me3 recognition, whereas the SET-and-RING-associated (SRA) domain binds to the plant homeodomain (PHD) and inhibits H3R2 recognition. Hm-DNA impairs the intramolecular interactions and promotes H3K9me3 recognition by TTD–PHD. The Spacer also facilitates UHRF1–DNMT1 interaction and enhances hm-DNA-binding affinity of the SRA. When TTD–PHD binds to H3K9me3, SRA-Spacer may exist in a dynamic equilibrium: either recognizes hm-DNA or recruits DNMT1 to chromatin. Our study reveals the mechanism for regulation of H3K9me3 and hm-DNA recognition by URHF1.
- 5 April 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11197
Open AccessHemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its histone recognition
UHRF1 is an important epigenetic regulator for maintenance DNA methylation. UHRF1 recognizes hemi-methylated DNA (hm-DNA) and trimethylation of histone H3K9 (H3K9me3), but the regulatory mechanism remains unknown. Here we show that UHRF1 adopts a closed conformation, in which a C-terminal region (Spacer) binds to the tandem Tudor domain (TTD) and inhibits H3K9me3 recognition, whereas the SET-and-RING-associated (SRA) domain binds to the plant homeodomain (PHD) and inhibits H3R2 recognition. Hm-DNA impairs the intramolecular interactions and promotes H3K9me3 recognition by TTD–PHD. The Spacer also facilitates UHRF1–DNMT1 interaction and enhances hm-DNA-binding affinity of the SRA. When TTD–PHD binds to H3K9me3, SRA-Spacer may exist in a dynamic equilibrium: either recognizes hm-DNA or recruits DNMT1 to chromatin. Our study reveals the mechanism for regulation of H3K9me3 and hm-DNA recognition by URHF1.
- Open Access
- 11 May 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7023
Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation
DNMT1 is an important epigenetic regulator that plays a key role in the maintenance of DNA methylation. Here we determined the crystal structure of DNMT1 in complex with USP7 at 2.9 Å resolution. The interaction between the two proteins is primarily mediated by an acidic pocket in USP7 and Lysine residues within DNMT1’s KG linker. This intermolecular interaction is required for USP7-mediated stabilization of DNMT1. Acetylation of the KG linker Lysine residues impair DNMT1–USP7 interaction and promote the degradation of DNMT1. Treatment with HDAC inhibitors results in an increase in acetylated DNMT1 and decreased total DNMT1 protein. This negative correlation is observed in differentiated neuronal cells and pancreatic cancer cells. Our studies reveal that USP7-mediated stabilization of DNMT1 is regulated by acetylation and provide a structural basis for the design of inhibitors, targeting the DNMT1–USP7 interaction surface for therapeutic applications.
- 11 May 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7023
Open AccessMolecular mechanism for USP7-mediated DNMT1 stabilization by acetylation
DNMT1 is an important epigenetic regulator that plays a key role in the maintenance of DNA methylation. Here we determined the crystal structure of DNMT1 in complex with USP7 at 2.9 Å resolution. The interaction between the two proteins is primarily mediated by an acidic pocket in USP7 and Lysine residues within DNMT1’s KG linker. This intermolecular interaction is required for USP7-mediated stabilization of DNMT1. Acetylation of the KG linker Lysine residues impair DNMT1–USP7 interaction and promote the degradation of DNMT1. Treatment with HDAC inhibitors results in an increase in acetylated DNMT1 and decreased total DNMT1 protein. This negative correlation is observed in differentiated neuronal cells and pancreatic cancer cells. Our studies reveal that USP7-mediated stabilization of DNMT1 is regulated by acetylation and provide a structural basis for the design of inhibitors, targeting the DNMT1–USP7 interaction surface for therapeutic applications.
- Open Access
- 4 February 2015
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 6 (4) , 275-287
Structural insight into mechanisms for dynamic regulation of PKM2
Pyruvate kinase isoform M2 (PKM2) converts phosphoenolpyruvate (PEP) to pyruvate and plays an important role in cancer metabolism. Here, we show that post-translational modifications and a patient-derived mutation regulate pyruvate kinase activity of PKM2 through modulating the conformation of the PKM2 tetramer. We determined crystal structures of human PKM2 mutants and proposed a “seesaw” model to illustrate conformational changes between an inactive T-state and an active R-state tetramers of PKM2. Biochemical and structural analyses demonstrate that PKM2Y105E (phosphorylation mimic of Y105) decreases pyruvate kinase activity by inhibiting FBP (fructose 1,6-bisphosphate)-induced R-state formation, and PKM2K305Q (acetylation mimic of K305) abolishes the activity by hindering tetramer formation. K422R, a patient-derived mutation of PKM2, favors a stable, inactive T-state tetramer because of strong intermolecular interactions. Our study reveals the mechanism for dynamic regulation of PKM2 by post-translational modifications and a patient-derived mutation and provides a structural basis for further investigation of other modifications and mutations of PKM2 yet to be discovered.
- 4 February 2015
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 6 (4) , 275-287
Open AccessStructural insight into mechanisms for dynamic regulation of PKM2
Pyruvate kinase isoform M2 (PKM2) converts phosphoenolpyruvate (PEP) to pyruvate and plays an important role in cancer metabolism. Here, we show that post-translational modifications and a patient-derived mutation regulate pyruvate kinase activity of PKM2 through modulating the conformation of the PKM2 tetramer. We determined crystal structures of human PKM2 mutants and proposed a “seesaw” model to illustrate conformational changes between an inactive T-state and an active R-state tetramers of PKM2. Biochemical and structural analyses demonstrate that PKM2Y105E (phosphorylation mimic of Y105) decreases pyruvate kinase activity by inhibiting FBP (fructose 1,6-bisphosphate)-induced R-state formation, and PKM2K305Q (acetylation mimic of K305) abolishes the activity by hindering tetramer formation. K422R, a patient-derived mutation of PKM2, favors a stable, inactive T-state tetramer because of strong intermolecular interactions. Our study reveals the mechanism for dynamic regulation of PKM2 by post-translational modifications and a patient-derived mutation and provides a structural basis for further investigation of other modifications and mutations of PKM2 yet to be discovered.
- Open Access
- 21 November 2014
- Published by Springer Nature in Cell Research
- Vol. 24 (12) , 1493-1496
Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine
- 21 November 2014
- Published by Springer Nature in Cell Research
- Vol. 24 (12) , 1493-1496
Open AccessCrystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine
- 1 April 2013
- Published by Elsevier in Cancer Cell
- Vol. 23 (4) , 464-476
Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
- 1 April 2013
- Published by Elsevier in Cancer Cell
- Vol. 23 (4) , 464-476
Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
- 1 February 2013
- Published by Elsevier in Molecular Cell
- Vol. 49 (3) , 558-570
LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 Demethylation
- 1 February 2013
- Published by Elsevier in Molecular Cell
- Vol. 49 (3) , 558-570
LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 Demethylation
- 29 January 2013
- Published by Springer Nature in Cell Research
- Vol. 23 (2) , 306-309
Structural insight into substrate recognition by histone demethylase LSD2/KDM1b
- 29 January 2013
- Published by Springer Nature in Cell Research
- Vol. 23 (2) , 306-309
Structural insight into substrate recognition by histone demethylase LSD2/KDM1b
- Open Access
- 1 January 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (2) , 1329-1339
Structural Insight into Coordinated Recognition of Trimethylated Histone H3 Lysine 9 (H3K9me3) by the Plant Homeodomain (PHD) and Tandem Tudor Domain (TTD) of UHRF1 (Ubiquitin-like, Containing PHD and RING Finger Domains, 1) Protein
- 1 January 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (2) , 1329-1339
Open AccessStructural Insight into Coordinated Recognition of Trimethylated Histone H3 Lysine 9 (H3K9me3) by the Plant Homeodomain (PHD) and Tandem Tudor Domain (TTD) of UHRF1 (Ubiquitin-like, Containing PHD and RING Finger Domains, 1) Protein